NeOnc Technologies Holdings, Inc.

Contributing Author

Recent Articles by NeOnc Technologies Holdings, Inc.

Oct-09	NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42's IROS and Expands Board of Directors NTHI GlobeNewswire
Oct-06	NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals NTHI GlobeNewswire
Oct-02	NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board NTHI GlobeNewswire
Oct-01	NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health's Perlmutter Cancer Center, to Its Scientific Advisory Board NTHI GlobeNewswire
Sep-29	NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board NTHI GlobeNewswire
Sep-22	NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on "Health Uncensored with Dr. Drew" on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT NTHI GlobeNewswire
Sep-10	NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 - A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer NTHI GlobeNewswire
Aug-25	NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board NTHI GlobeNewswire
Aug-19	NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update NTHI GlobeNewswire
Aug-11	NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation NTHI GlobeNewswire
Aug-07	NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia NTHI GlobeNewswire
Aug-04	NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer NTHI GlobeNewswire
Jul-30	NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors NTHI GlobeNewswire
Jul-29	NeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment NTHI GlobeNewswire
Jul-28	NeOnc Technologies to Participate at the BTIG Virtual Biotechnology Conference NTHI GlobeNewswire
Jul-23	CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc. NTHI GlobeNewswire
Jul-23	NeOnc Technologies' Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks - Today at 11:00 a.m. ET NTHI GlobeNewswire
Jul-22	NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment NTHI GlobeNewswire
Jul-10	NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment NTHI GlobeNewswire
Jul-09	NeOnc Technologies Holdings, Inc. Joins Russell Microcap Index NTHI GlobeNewswire
Jul-08	NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform NTHI GlobeNewswire
Jun-06	NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs NTHI GlobeNewswire

NeOnc Technologies Holdings, Inc.

Recent Articles by NeOnc Technologies Holdings, Inc.

Upgrade your FINVIZ experience